146 related articles for article (PubMed ID: 36681188)
21. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
[TBL] [Abstract][Full Text] [Related]
22. A four gene signature predictive of recurrent prostate cancer.
Komisarof J; McCall M; Newman L; Bshara W; Mohler JL; Morrison C; Land H
Oncotarget; 2017 Jan; 8(2):3430-3440. PubMed ID: 27966447
[TBL] [Abstract][Full Text] [Related]
23. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
[TBL] [Abstract][Full Text] [Related]
24. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
Donovan MJ; Hamann S; Clayton M; Khan FM; Sapir M; Bayer-Zubek V; Fernandez G; Mesa-Tejada R; Teverovskiy M; Reuter VE; Scardino PT; Cordon-Cardo C
J Clin Oncol; 2008 Aug; 26(24):3923-9. PubMed ID: 18711180
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
[TBL] [Abstract][Full Text] [Related]
26. Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?
Ludwig WW; Feng Z; Trock BJ; Humphreys E; Walsh PC
J Urol; 2018 Jan; 199(1):114-119. PubMed ID: 28818527
[TBL] [Abstract][Full Text] [Related]
27. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.
Cullen J; Rosner IL; Brand TC; Zhang N; Tsiatis AC; Moncur J; Ali A; Chen Y; Knezevic D; Maddala T; Lawrence HJ; Febbo PG; Srivastava S; Sesterhenn IA; McLeod DG
Eur Urol; 2015 Jul; 68(1):123-31. PubMed ID: 25465337
[TBL] [Abstract][Full Text] [Related]
28. Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
Dietrich D; Hasinger O; Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Wernert N; Perner S; Freedland SJ; Corman JM; Ittmann MM; Lark AL; Madden JF; Hartmann A; Schatz P; Kristiansen G
J Mol Diagn; 2013 Mar; 15(2):270-9. PubMed ID: 23266319
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.
Loeb S; Folkvaljon Y; Robinson D; Lissbrant IF; Egevad L; Stattin P
Eur Urol; 2016 Jun; 69(6):1135-41. PubMed ID: 26707871
[TBL] [Abstract][Full Text] [Related]
30. Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.
Glass AG; Leo MC; Haddad Z; Yousefi K; du Plessis M; Chen C; Choeurng V; Abdollah F; Robbins B; Ra S; Richert-Boe KE; Buerki C; Pearson K; Davicioni E; Weinmann S
J Urol; 2016 Jun; 195(6):1748-53. PubMed ID: 26626216
[TBL] [Abstract][Full Text] [Related]
31. Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.
Lee G; Veltri RW; Zhu G; Ali S; Epstein JI; Madabhushi A
Eur Urol Focus; 2017 Oct; 3(4-5):457-466. PubMed ID: 28753763
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy.
Freedland SJ; Csathy GS; Dorey F; Aronson WJ
Urology; 2002 Jul; 60(1):84-8. PubMed ID: 12100929
[TBL] [Abstract][Full Text] [Related]
33. Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy.
Briganti A; Karnes RJ; Joniau S; Boorjian SA; Cozzarini C; Gandaglia G; Hinkelbein W; Haustermans K; Tombal B; Shariat S; Sun M; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Eur Urol; 2014 Sep; 66(3):479-86. PubMed ID: 24345725
[TBL] [Abstract][Full Text] [Related]
34. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract][Full Text] [Related]
35. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
36. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
37. Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.
Leo P; Chandramouli S; Farré X; Elliott R; Janowczyk A; Bera K; Fu P; Janaki N; El-Fahmawi A; Shahait M; Kim J; Lee D; Yamoah K; Rebbeck TR; Khani F; Robinson BD; Shih NNC; Feldman M; Gupta S; McKenney J; Lal P; Madabhushi A
Eur Urol Focus; 2021 Jul; 7(4):722-732. PubMed ID: 33941504
[TBL] [Abstract][Full Text] [Related]
38. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
[TBL] [Abstract][Full Text] [Related]
39. Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients.
Bhargava HK; Leo P; Elliott R; Janowczyk A; Whitney J; Gupta S; Fu P; Yamoah K; Khani F; Robinson BD; Rebbeck TR; Feldman M; Lal P; Madabhushi A
Clin Cancer Res; 2020 Apr; 26(8):1915-1923. PubMed ID: 32139401
[TBL] [Abstract][Full Text] [Related]
40. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy.
Han M; Snow PB; Epstein JI; Chan TY; Jones KA; Walsh PC; Partin AW
Urology; 2000 Dec; 56(6):994-9. PubMed ID: 11113746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]